Islet autoreactive CD8 T-cells in type 1 diabetes: Licensed to kill?

Diabetes

Volumn 57, Issue 5, 2008, Pages 1156-1157

  Roep, Bart O ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A2 ANTIGEN;

CD8+ T LYMPHOCYTE; CYTOKINE PRODUCTION; DISEASE ACTIVITY; DISEASE COURSE; ENZYME LINKED IMMUNOSPOT ASSAY; GENETIC PREDISPOSITION; HUMAN; IMMUNOREACTIVITY; IMMUNOTHERAPY; INSULIN DEPENDENT DIABETES MELLITUS; NOTE; PANCREAS ISLET CELL; PRIORITY JOURNAL; CYTOTOXIC T LYMPHOCYTE; IMMUNOLOGY; LYMPHOCYTE COUNT; PANCREAS ISLET; PANCREAS ISLET BETA CELL; REFERENCE VALUE; REPRODUCIBILITY;

CD8-POSITIVE T-LYMPHOCYTES; DIABETES MELLITUS, TYPE 1; HUMANS; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS; LYMPHOCYTE COUNT; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 48449094385     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db08-0264     Document Type: Note

References (18)

1. Roep BO, Kalian AA, Duinkerken G, Arden SD, Hutton JC, Braining GJ, de Vries RR: T-cell reactivity to beta-cell membrane antigens associated with beta-cell destruction in IDDM. Diabetes 44:278-283, 1995
2. In't Veld P, Lievens D, De GJ, Ling Z, Van der Auwera B, Pipeleers-Marichal M, Gorus F, Pipeleers D: Screening for insulitis in adult autoantibody-positive organ donors. Diabetes 56:2400-2404, 2007
3. Nejentsev S, Howson JM, Walker NM, Szeszko J, Field SF, Stevens HE, Reynolds P, Hardy M, King E, Masters J, Hulme J, Maier LM, Smyth D, Bailey R, Cooper JD, Ribas G, Campbell RD, Clayton DG, Todd JA: Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A. Nature 450:887-892, 2007
4. Roep BO: Diabetes: missing links. Nature 450:799-800, 2007
5. Toma A, Haddouk S, Briand JP, Camoin L, Gahery H, Connan F, Dubois-Laforgue D, Caillat-Zucman S, Guillet JG, Carel JC, Muller S, Choppin J, Boitard C: Recognition of a subregion of human proinsulin by class I-restricted T cells in type 1 diabetic patients. Proc Natl Acad Sci USA 102:10581-10586, 2005
6. Pinkse GG, Tysma OH, Bergen CA, Kester MG, Ossendorp F, van Veelen PA, Keymeulen B, Pipeleers D, Drijfhout JW, Roep BO: Autoreactive CD8 T cells associated with beta cell destruction in type 1 diabetes. Proc Natl Acad Sci USA 102:18425-18430, 2005
7. Hassainya Y, Garcia-Pons F, Kratzer R, Lindo V, Greer F, Lemonnier FA, Niedermann G, van Endert PM: Identification of naturally processed HLA-A2-restricted proinsulin epitopes by reverse immunology. Diabetes 54:2053-2059, 2005
8. Mallone R, Martinuzzi E, Blancou P, Novelli G, Afonso G, Dolz M, Bruno G, Chaillous L, Chatenoud L, Bach JM, van EP: CD8+ T-cell responses identify β-cell autoimmunity in human type 1 diabetes. Diabetes 56:613-621, 2007
9. Ouyang Q, Standifer NE, Qin H, Gottlieb P, Verchere CB, Nepom GT, Tan R, Panagiotopoulos C: Recognition of HLA class I-restricted β-cell epitopes in type 1 diabetes. Diabetes 55:3068-3074, 2006
10. Standifer NE, Ouyang Q, Panagiotopoulos C, Verchere CB, Tan R, Green-baum CJ, Pihoker C, Nepom GT: Identification of novel HLA-A*0201-restricted epitopes in recent-onset type 1 diabetic subjects and antibody-positive relatives. Diabetes 55:3061-3067, 2006
11. Pinkse GG, Boitard C, Tree TI, Peakman M, Roep BO: HLA class I epitope discovery in type 1 diabetes: independent and reproducible identification of proinsulin epitopes of CD8 T cells: report of the IDS T Cell Workshop Committee. Ann NY Acad Sci 1079:19-23, 2006
12. Martinuzzi E, Novelli G, Scotto M, Blancou P, Bach GM, Chaillous L, Bruno G, Chatenoud L, van Endert P, Mallone R: The frequency and immu-nodominance of islet-specific CD8+ T-cell responses change after type 1 diabetes diagnosis and treatment. Diabetes 57:1312-1320, 2008
13. Unger WW, Pinkse GG, Mulder-Van der Kracht S, van der Slik AR, Kester MG, Ossendorp F, Drijfhout JW, Serreze DV, Roep BO: Human clonal CD8 autoreactivity to an IGRP islet epitope shared between mice and men. Ann NY Acad Sci 1103:192-195, 2007
14. Di Lorenzo TP, Peakman M, Roep BO: Translational mini-review series on type 1 diabetes: systematic analysis of T cell epitopes in autoimmune diabetes. Clin Exp Immunol 148:1-16, 2007
15. Wenzlau JM, Juhl K, Yu L, Moua O, Sarkar SA, Gottlieb P, Rewers M, Eisenbarth GS, Jensen J, Davidson HW, Hutton JC: The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc Natl Acad Sci USA 104:17040-17045, 2007
16. Keymeulen B, Vandemeulebroucke E, Ziegler AG, Mathieu C, Kaufman L, Hale G, Gorus F, Goldman M, Walter M, Candon S, Schandene L, Crenier L, De BC, Seigneurin JM, De PP, Pierard D, Weets I, Rebello P, Bird P, Berrie E, Frewin M, Waldmann H, Bach JF, Pipeleers D, Chatenoud L: Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. N Engl J Med 352:2598-2608, 2005
17. Herold KC, Hagopian W, Auger JA, Poumian-Ruiz E, Taylor L, Donaldson D, Gitelman SE, Harlan DM, Xu D, Zivin RA, Bluestone JA: Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus. N Engl J Med 346:1692-1698, 2002
18. Bisikirska B, Colgan J, Luban J, Bluestone JA, Herold KC: TCR stimulation with modified anti-CD3 mAb expands CD8+ T cell population and induces CD8+CD25+ Tregs. J Clin Invest 115:2904-2913, 2005